FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128092404> ?p ?o ?g. }

• W3128092404 endingPage "1838" @default.
• W3128092404 startingPage "1828" @default.
• W3128092404 abstract "The GIMEMA LAL1509 protocol, designed for adult (≥18-60 years) de novo Ph+ acute lymphoblastic leukemia patients, was based on a dasatinib plus steroids induction - with central nervous system prophylaxis - followed by dasatinib alone in patients in complete molecular response or chemotherapy and/or allogeneic transplantation in patients not reaching a complete molecular response. Sixty patients (median age 41.9 years) were enrolled: 33 were p190+, 18 p210+ and 9 p190/p210+. At the end of induction (day +85), 58 patients (97%) achieved a complete hematologic remission. No deaths in induction were recorded. Eleven patients (18.3%) obtained a complete molecular response. Among non-complete molecular responders (n=47), 22 underwent an allogeneic transplant. Seventeen hematologic relapses occurred (median 7 months, range 3-40.1), 13 during consolidation and 4 post-transplant. ABL1 mutations (5 T315I, 3 V299L, 1 E281K and 1 G254E) were found in 10/13 relapsed cases. With a median follow-up of 57.4 months (range: 4.2-75.6), overall survival and disease-free survival are 56.3% and 47.2%. A better diseasefree survival was observed in patients who obtained a molecular response at day +85 compared to cases who did not. The presence of additional copy number aberrations - IKZF1 plus CDKN2A/B and/or PAX5 deletions - was the most important unfavorable prognostic factor on overall and disease-free survival (p=0.005 and p=0.0008). This study shows that in adult Ph+ ALL long-term survivals can be achieved with a total-therapy strategy based on a chemo-free induction and, in complete molecular responders, also without further systemic chemotherapy. Finally, the screening of additional copy number aberrations should be included in the diagnostic work-up. EudraCT 2010-019119-39" @default.
• W3128092404 created "2021-02-15" @default.
• W3128092404 creator A5000173301 @default.
• W3128092404 creator A5004295563 @default.
• W3128092404 creator A5008054206 @default.
• W3128092404 creator A5009431453 @default.
• W3128092404 creator A5010652260 @default.
• W3128092404 creator A5011614506 @default.
• W3128092404 creator A5012014901 @default.
• W3128092404 creator A5013524794 @default.
• W3128092404 creator A5016635620 @default.
• W3128092404 creator A5018952464 @default.
• W3128092404 creator A5020789491 @default.
• W3128092404 creator A5021908105 @default.
• W3128092404 creator A5025347398 @default.
• W3128092404 creator A5034393745 @default.
• W3128092404 creator A5041181079 @default.
• W3128092404 creator A5041966654 @default.
• W3128092404 creator A5042609656 @default.
• W3128092404 creator A5043145355 @default.
• W3128092404 creator A5070767391 @default.
• W3128092404 creator A5073761054 @default.
• W3128092404 creator A5078192708 @default.
• W3128092404 creator A5085216234 @default.
• W3128092404 creator A5087250949 @default.
• W3128092404 date "2021-02-04" @default.
• W3128092404 modified "2023-10-14" @default.
• W3128092404 title "A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol" @default.
• W3128092404 cites W1506738181 @default.
• W3128092404 cites W1673031009 @default.
• W3128092404 cites W1931165463 @default.
• W3128092404 cites W1972060994 @default.
• W3128092404 cites W1994309500 @default.
• W3128092404 cites W2000116184 @default.
• W3128092404 cites W2003041273 @default.
• W3128092404 cites W2030796837 @default.
• W3128092404 cites W2033862877 @default.
• W3128092404 cites W2036862498 @default.
• W3128092404 cites W2037148599 @default.
• W3128092404 cites W2065851457 @default.
• W3128092404 cites W2068420766 @default.
• W3128092404 cites W2070464547 @default.
• W3128092404 cites W2087090648 @default.
• W3128092404 cites W2089224414 @default.
• W3128092404 cites W2089360398 @default.
• W3128092404 cites W2093274439 @default.
• W3128092404 cites W2099616647 @default.
• W3128092404 cites W2102929198 @default.
• W3128092404 cites W2105908490 @default.
• W3128092404 cites W2137520438 @default.
• W3128092404 cites W2148854558 @default.
• W3128092404 cites W2158106590 @default.
• W3128092404 cites W2344488712 @default.
• W3128092404 cites W2509076190 @default.
• W3128092404 cites W2566332174 @default.
• W3128092404 cites W2785037227 @default.
• W3128092404 cites W2790671015 @default.
• W3128092404 cites W2802056043 @default.
• W3128092404 cites W2892257538 @default.
• W3128092404 cites W2902317207 @default.
• W3128092404 cites W2941550162 @default.
• W3128092404 cites W2944434778 @default.
• W3128092404 cites W2965220174 @default.
• W3128092404 cites W2986868459 @default.
• W3128092404 cites W3093938683 @default.
• W3128092404 doi "https://doi.org/10.3324/haematol.2020.260935" @default.
• W3128092404 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8252956" @default.
• W3128092404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33538150" @default.
• W3128092404 hasPublicationYear "2021" @default.
• W3128092404 type Work @default.
• W3128092404 sameAs 3128092404 @default.
• W3128092404 citedByCount "26" @default.
• W3128092404 countsByYear W31280924042021 @default.
• W3128092404 countsByYear W31280924042022 @default.
• W3128092404 countsByYear W31280924042023 @default.
• W3128092404 crossrefType "journal-article" @default.
• W3128092404 hasAuthorship W3128092404A5000173301 @default.
• W3128092404 hasAuthorship W3128092404A5004295563 @default.
• W3128092404 hasAuthorship W3128092404A5008054206 @default.
• W3128092404 hasAuthorship W3128092404A5009431453 @default.
• W3128092404 hasAuthorship W3128092404A5010652260 @default.
• W3128092404 hasAuthorship W3128092404A5011614506 @default.
• W3128092404 hasAuthorship W3128092404A5012014901 @default.
• W3128092404 hasAuthorship W3128092404A5013524794 @default.
• W3128092404 hasAuthorship W3128092404A5016635620 @default.
• W3128092404 hasAuthorship W3128092404A5018952464 @default.
• W3128092404 hasAuthorship W3128092404A5020789491 @default.
• W3128092404 hasAuthorship W3128092404A5021908105 @default.
• W3128092404 hasAuthorship W3128092404A5025347398 @default.
• W3128092404 hasAuthorship W3128092404A5034393745 @default.
• W3128092404 hasAuthorship W3128092404A5041181079 @default.
• W3128092404 hasAuthorship W3128092404A5041966654 @default.
• W3128092404 hasAuthorship W3128092404A5042609656 @default.
• W3128092404 hasAuthorship W3128092404A5043145355 @default.
• W3128092404 hasAuthorship W3128092404A5070767391 @default.
• W3128092404 hasAuthorship W3128092404A5073761054 @default.
• W3128092404 hasAuthorship W3128092404A5078192708 @default.
• W3128092404 hasAuthorship W3128092404A5085216234 @default.

• next